World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
81
Citations
20763
World Ranking
1109
National Ranking
504

Molecular Biology

D-Index
80
Citations
19224
World Ranking
1015
National Ranking
534

John N. Brady publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where John N. Brady sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 181 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

John N. Brady D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where John N. Brady sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 1959 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John N. Brady is affiliated with the National Institutes of Health in the United States. Their research primarily spans the field of Medicine, focusing on several subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research, Spectroscopy, and Physiology.

Their work covers a range of topics within these areas, notably in Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Mass Spectrometry Techniques and Applications, Syphilis Diagnosis and Treatment, Reproductive Tract Infections Research, as well as Occupational Health and Safety Research.

The scientist has contributed to multiple peer-reviewed publications in recognized venues such as The Lancet Oncology, Journal of Clinical Oncology, Abstracts, BMJ Open, and Pathology. Recent papers demonstrate a focus on clinical trials and diagnostic investigations, including:

  • Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial (2025, The Lancet Oncology)
  • Phase Ib/IIa dose escalation and expansion study of [ 212 Pb]Pb-ADVC001 in metastatic castration-resistant prostate cancer: TheraPb-phase I/II study (2025, Journal of Clinical Oncology)
  • O21 Navigating a procaine penicillin shortage: clinical outcomes in ceftriaxone-treated neurosyphilis (2022, Abstracts)
  • Understanding and enhancing responses to distress in the construction industry: protocol for a data linkage study (2022, BMJ Open)
  • Extragonadal teratoma in a fallopian tube; a common entity in an uncommon location (2024, Pathology)

The scientist has collaborated frequently with other researchers in the field. Notable coauthors include David A. Pattison, Jeffrey C. Goh, Louise Emmett, Nathan Papa, and Shalini Subramaniam.

In recognition of their contributions, John N. Brady was awarded the Fellowship of the American Association for the Advancement of Science (AAAS) in 1959.

Best Publications

  • The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.

    Moon Kyoo Jang;Kazuki Mochizuki;Meisheng Zhou;Ho-Sang Jeong

  • Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

    Rong Zeng;Rosanne Spolski;Steven E. Finkelstein;Sang Kon Oh

  • Characterization and isolation of stem cell–enriched human hair follicle bulge cells

    Manabu Ohyama;Atsushi Terunuma;Christine L. Tock;Michael F. Radonovich

  • Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

    Barbara Ensoli;Rita Gendelman;Phillip Markham;Valeria Fiorelli

  • Phosphorylation of p53 serine 15 increases interaction with CBP

    Paul F. Lambert;Fatah Kashanchi;Michael F. Radonovich;Ramin Shiekhattar

  • Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.

    Changqing Ju;Timothy P. Reilly;Mohammed Bourdi;Michael F. Radonovich

  • A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.

    Tomas Bonome;Douglas A. Levine;Joanna H. Shih;Mike Randonovich

  • Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

    Tomas Bonome;Ji Young Lee;Dong Choon Park;Mike Radonovich

  • Identification of Kaposin (Open Reading Frame K12) as a Human Herpesvirus 8 (Kaposi’s Sarcoma-Associated Herpesvirus) Transforming Gene

    Sumitra Muralidhar;Anne M. Pumfery;Morad Hassani;M. Reza Sadaie

  • Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription

    Meisheng Zhou;Matthew A. Halanski;Michael F. Radonovich;Fatah Kashanchi

  • Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat.

    J Brady;K T Jeang;J Duvall;G Khoury

  • Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway.

    Anath Shalev;Cynthia A. Pise-Masison;Michael Radonovich;Steven C. Hoffmann

  • Direct interaction of human TFIID with the HIV-1 transactivator Tat

    Fatah Kashanchi;Graziella Piras;Michael F. Radonovich;Janet F. Duvall

  • Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.

    K T Jeang;I Boros;J Brady;M Radonovich

  • A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

    Samuel C. Mok;Tomas Bonome;Vinod Vathipadiekal;Aaron Bell

  • Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.

    Soo-Jin Jeong;Cynthia A Pise-Masison;Michael F Radonovich;Hyeon Ung Park

  • Inhibition of p53 Transactivation Function by the Human T-Cell Lymphotropic Virus Type 1 Tax Protein

    Cynthia A. Pise-Masison;Kyeong-Sook Choi;Michael Radonovich;Jürgen Dittmer

  • Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen

    John Brady;Joseph B. Bolen;Michael Radonovich;Norman Salzman

  • IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes

    Hai-Hui Xue;Panu E. Kovanen;Cynthia A. Pise-Masison;Maria Berg

  • Tat gets the "green" light on transcription initiation

    John Brady;Fatah Kashanchi

Frequent Co-Authors

Fatah Kashanchi
Fatah Kashanchi George Mason University
Renaud Mahieux
Renaud Mahieux École Normale Supérieure de Lyon
Michael J. Birrer
Michael J. Birrer University of Arkansas for Medical Sciences
George Khoury
George Khoury National Institutes of Health
Samuel C. Mok
Samuel C. Mok The University of Texas MD Anderson Cancer Center
Antoine Gessain
Antoine Gessain Institut Pasteur
Christophe Nicot
Christophe Nicot University of Kansas
Lance R. Pohl
Lance R. Pohl National Institutes of Health
Ke Hao
Ke Hao Icahn School of Medicine at Mount Sinai
Kamel Khalili
Kamel Khalili Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to diverse academic and professional opportunities. Many students consider interdisciplinary or complementary studies to expand their skills and career prospects. For instance, some may pursue a best online history masters to understand science through a historical or societal lens.

If you're interested in supporting information resources in scientific research, you might look at what schools offer library science degrees. Library scientists play an essential role in managing academic and medical databases, which are vital to the molecular biology field.

For those drawn to health and communication sciences, molecular biology knowledge is valuable in allied health careers such as speech-language pathology. There are now a variety of asha approved online speech pathology programs designed for those interested in clinical work or research.

Non-traditional students or career changers may benefit from speech pathology bridge programs that provide pathways for individuals without a related undergraduate degree to enter the field.

Best Scientists Citing John N. Brady

Recently Published Articles